These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19671805)

  • 41. Definition of clinical differences.
    de Vet HC; Beckerman H; Terwee CB; Terluin B; Bouter LM
    J Rheumatol; 2006 Feb; 33(2):434; author reply 435. PubMed ID: 16465677
    [No Abstract]   [Full Text] [Related]  

  • 42. Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
    Shmerling RH
    Arch Intern Med; 2009 Jan; 169(1):9-14. PubMed ID: 19139318
    [No Abstract]   [Full Text] [Related]  

  • 43. Association of polymorphisms in interleukin-10 gene promoter with autoantibody production in patients with rheumatoid arthritis.
    Nemec P; Goldbergova MP; Gatterova J; Vasku A; Soucek M
    Ann N Y Acad Sci; 2009 Sep; 1173():501-8. PubMed ID: 19758192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early arthritis clinics: if you build it will they come?
    Cush JJ
    J Rheumatol; 2005 Feb; 32(2):203-7. PubMed ID: 15693079
    [No Abstract]   [Full Text] [Related]  

  • 45. [The vicious circle that leads to rheumatoid arthritis; experimental evidence of the steps involved in this circle].
    van Venrooij WJ; Pruijn GJ
    Ned Tijdschr Geneeskd; 2009; 153():B232. PubMed ID: 19785789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Not steroids again.
    Russell A
    J Rheumatol; 2007 Sep; 34(9):1942; author reply 1942-3. PubMed ID: 17787054
    [No Abstract]   [Full Text] [Related]  

  • 47. Citrullinated antigens: just diagnostic tools or pathogenic targets in rheumatoid arthritis?
    Feist E; Burmester GR
    J Rheumatol; 2006 Nov; 33(11):2103-4. PubMed ID: 17086596
    [No Abstract]   [Full Text] [Related]  

  • 48. [Significance of antibodies to cyclic citrullinized peptide in diagnostics of rheumatoid arthritis].
    Cheremis NA; Nasonov EL
    Klin Med (Mosk); 2005; 83(8):48-53. PubMed ID: 16218364
    [No Abstract]   [Full Text] [Related]  

  • 49. "ACPA" in Rheumatoid Arthritis: From Population-based Data to Personalized Medicine.
    Ménard HA
    J Rheumatol; 2015 May; 42(5):733-5. PubMed ID: 25934875
    [No Abstract]   [Full Text] [Related]  

  • 50. A database in private practice: the Brooklyn Outcomes of Arthritis Rheumatology Database (BOARD).
    Yazici Y
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S182-7. PubMed ID: 16273805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Issues in rheumatology and autoimmunity. Preface.
    Sherer Y
    Isr Med Assoc J; 2008 Feb; 10(2):138. PubMed ID: 18432028
    [No Abstract]   [Full Text] [Related]  

  • 52. [Rheumatoid arthritis: earlier and more aggressive therapies].
    Kathmann W
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():58-9. PubMed ID: 16379242
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care.
    Pincus T; Yazici Y; Bergman M
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S19-28. PubMed ID: 16273781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rheumatoid arthritis and arthrosis: we can do a lot but supporting research is indispensable].
    Sénécal JL
    Union Med Can; 1993; 122(2):66-72. PubMed ID: 8493739
    [No Abstract]   [Full Text] [Related]  

  • 55. Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis.
    Varadé J; Loza-Santamaría E; Fernández-Arquero M; Lamas JR; de Los Angeles Figueredo M; Jover JA; de la Concha EG; Rodríguez L; Urcelay E; Fernández-Gutiérrez B; Martínez-Doncel A
    J Rheumatol; 2009 May; 36(5):1085-6. PubMed ID: 19435975
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diagnosis and treatment of rheumatoid arthritis should be stardarized].
    Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):971-3. PubMed ID: 15312527
    [No Abstract]   [Full Text] [Related]  

  • 57. The need for new classification criteria for rheumatoid arthritis.
    Aletaha D; Breedveld FC; Smolen JS
    Arthritis Rheum; 2005 Nov; 52(11):3333-6. PubMed ID: 16255014
    [No Abstract]   [Full Text] [Related]  

  • 58. Hotel-based rheumatology, and more.
    Leeb BF
    J Rheumatol; 2009 Feb; 36(2):455-6; author reply 456-7. PubMed ID: 19208582
    [No Abstract]   [Full Text] [Related]  

  • 59. Improving outcomes in rheumatoid arthritis: what determines decisions to change ineffective therapy?
    Sokka T; Mäkinen H
    J Rheumatol; 2006 Jul; 33(7):1213-5. PubMed ID: 16821259
    [No Abstract]   [Full Text] [Related]  

  • 60. Outcome issues for rheumatoid arthritis: what do we have and what do we want?
    Albert DA
    J Rheumatol; 2006 Mar; 33(3):441-2. PubMed ID: 16511910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.